首页> 外文期刊>Liver international : >High prevalence of occult hepatitis B in hepatitis C-infected Egyptian children with haematological disorders and malignancies.
【24h】

High prevalence of occult hepatitis B in hepatitis C-infected Egyptian children with haematological disorders and malignancies.

机译:埃及的丙型肝炎感染的血液学疾病和恶性肿瘤患儿隐匿性乙型肝炎流行率很高。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

OBJECTIVE: This study investigates the prevalence of occult hepatitis B virus (HBV) in children and adolescents with haematological diseases with or without hepatitis C virus (HCV) infection. METHODS: Forty-nine children with haematological disorders (median age 11.4 years) and 51 with haematological malignancies (median age 8 years) were enrolled. Sera were tested for HCV antibodies, HCV-RNA [nested reverse transcriptase polymerase chain reaction (PCR)], HBV markers (HBsAg, anti-HBcAb IgM and total, HBeAg) and HBV-DNA (nested PCR for s, c and x regions). RESULTS: Anti-HCV was detected among 40/49 (81.6%) children with haematological disorders (24/49; 49% HCV-RNA positive) and 9/51 (17.6%) children with malignancies (12/51; 23.5% HCV-RNA positive). HBV-DNA was positive among 38%; positive c region in 33% (15/49 and 18/51 children with haematological disorders and malignancies respectively), s region in four leukaemics and x region in one leukaemic. Twenty-one patients had occult HBV infection; one (2.6%) was HBeAg positive, four (19%) total HBcAb positive, 20 (95.2%) c region HBV-DNA positive and one was s region positive (1/21; 4.8%). HCV-RNA was the significant predictor for occult HBV (P<0.05), with an increased frequency of HBV-DNA in the HBsAg negative (HCV-RNA positive) (63.2%) compared with patients negative for HCV-RNA (25%) (P=0.009). CONCLUSION: Occult HBV infection is not uncommon in transfused immunocompromised children with chronic HCV infection. Nucleic acid amplification should be considered in screening donors as post-transfusion hepatitis B viraemia may be substantial.
机译:目的:本研究调查了有或没有丙型肝炎病毒(HCV)感染的血液系统疾病的儿童和青少年中隐匿性乙型肝炎病毒(HBV)的患病率。方法:招募了49例血液系统疾病儿童(中位年龄11.4岁)和51例血液系统恶性肿瘤(中位年龄8岁)。检测血清中的HCV抗体,HCV-RNA [巢式逆转录酶聚合酶链反应(PCR)],HBV标记(HBsAg,抗HBcAb IgM和total,HBeAg)和HBV-DNA(在s,c和x区域进行巢式PCR) )。结果:40/49(81.6%)血液系统疾病儿童(24/49; 49%HCV-RNA阳性)和9/51(17.6%)恶性肿瘤儿童(12/51; 23.5%HCV)检测到抗HCV -RNA阳性)。 HBV-DNA阳性的占38%。阳性c区占33%(血液学疾病和恶性肿瘤患儿分别为15/49和18/51),四例白血病患者中的s区域和一例白血病患者中的x区域。隐匿性HBV感染21例; 1个(2.6%)为HBeAg阳性,四个(19%)HBcAb阳性,20个(95.2%)c区HBV-DNA阳性,一个为s区阳性(1/21; 4.8%)。 HCV-RNA是隐匿性HBV的重要预测因子(P <0.05),与HCV-RNA阴性的患者(25%)相比,HBsAg阴性(HCV-RNA阳性)的HBV-DNA发生率增加(63.2%) (P = 0.009)。结论:在慢性HCV感染的免疫功能低下的儿童中,隐匿性HBV感染并不罕见。筛查供体时应考虑核酸扩增,因为输血后乙型肝炎病毒血症可能很大。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号